Simplifying cancer screening with a new tool
Part of Cancer clinical trials.
This trial tests a new screening tool that helps doctors find cancer. It involves completing medical exams and questionnaires. The study is for people who have not had cancer in the last 5 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have completed all medical exams and questionnaires.
- You are willing and able to sign a consent form.
- You do not have any active cancer or have not had cancer in the last 5 years.
- You do not have polyposis syndromes or inflammatory bowel disease.
- You are not pregnant, breastfeeding, or currently have a fever.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This study uses a simple blood test (liquid biopsy) to find early signs of lung cancer in people who are at risk. It aims to catch lung cancer earlier, when it may be easier to treat.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.